Abstract
Exacerbated immune responses and loss of self-tolerance lead to the development of autoimmunity and immunopathology. Novel therapies to target autoreactive T cells are still needed. Here, we report that Th2-polarized T cells lacking the transcription factor T-bet harbor strong immunomodulatory potential and suppress antigen-specific CD8(+) T cells via IL-10. Tbx21(-/-) Th2 cells protected mice against virus-induced type 1 diabetes development and suppressed not only naive but also memory CD8(+) T cell responses. IL-10-producing, but not IL-10-deficient Tbx21(-/-) Th2 cells down-regulated costimulatory molecules on dendritic cells and reduced their IL-12 production after lymphocytic choriomeningitis virus infection. Impaired dendritic cell activation hindered effector and cytotoxic CD8(+) T cell development after infection. These findings indicate that Tbx21(-/-) Th2 cells strongly suppress proinflammatory responses of naive and memory T cells via IL-10. Thus, in vivo IL-10-secreting Th2 cells could harbor a therapeutic potential for the treatment of T cell-mediated inflammatory disorders.